|1.||Biot, Christophe: 6 articles (01/2014 - 04/2006)|
|2.||Dive, Daniel: 5 articles (01/2014 - 04/2006)|
|3.||Kremsner, Peter G: 4 articles (12/2015 - 12/2006)|
|4.||Ter-Minassian, Daniel: 3 articles (12/2015 - 01/2011)|
|5.||Supan, Christian: 3 articles (12/2015 - 01/2011)|
|6.||Lell, Bertrand: 3 articles (12/2015 - 01/2011)|
|7.||Khalife, Jamal: 3 articles (07/2013 - 04/2006)|
|8.||Brocard, Jacques: 3 articles (07/2006 - 04/2003)|
|9.||Kombila, Maryvonne: 2 articles (12/2015 - 01/2011)|
|10.||Mordmüller, Benjamin: 2 articles (12/2015 - 12/2006)|
08/01/2011 - "Ferroquine (FQ, SSR97193) is currently the most advanced organo-metallic drug candidate and about to complete phase II clinical trials as a treatment for uncomplicated malaria. "
07/22/2013 - "It is based on the production of HO(·) in the acidic and oxidizing environment of the digestive vacuole of the malaria parasite and implies that, with ferroquine, reinvasion can be inhibited."
02/01/2013 - "Ferroquine (FQ, SSR97193) is a synthetic compound currently in development for the treatment of malaria. "
11/15/2010 - "A bioorganometallic approach to malaria therapy led to the discovery of ferroquine (FQ, SSR97193). "
07/27/2006 - "A new therapeutic approach to malaria led to the discovery of ferroquine (FQ, SR97276). "
06/01/2012 - "Young male African volunteers with asymptomatic Plasmodium falciparum infection were administered a single oral dose (n = 40) or a repeated oral dose (n = 26) given over 3 days of ferroquine in two dose-escalation, double-blind, randomized, placebo-controlled clinical trials. "
01/01/2011 - "Phase I randomized dose-ascending placebo-controlled trials of ferroquine--a candidate anti-malarial drug--in adults with asymptomatic Plasmodium falciparum infection."
06/01/2012 - "Pharmacokinetics of ferroquine, a novel 4-aminoquinoline, in asymptomatic carriers of Plasmodium falciparum infections."
|3.||Falciparum Malaria (Plasmodium falciparum Malaria)
12/01/2015 - "Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study."
12/01/2015 - "Ferroquine combined with artesunate was associated with high cure rates and was safe at all doses tested, and could be a promising new drug combination for the treatment of P falciparum malaria. "
12/01/2015 - "We aimed to assess different doses of ferroquine in combination with artesunate against uncomplicated P falciparum malaria in a heterogeneous population in Africa. "
12/01/2011 - "Ferroquine (FQ), a chloroquine (CQ) analog, is being developed to treat persons with Plasmodium falciparum malaria. "
01/01/2014 - "Ferroquine as an oxidative shock antimalarial."
|2.||Antimalarials (Antimalarial Agents)